Extramedullary Hematopoiesis in Treated Diffuse Large B-Cell Lymphoma of Bone

被引:0
|
作者
Chaouki, Amine [1 ,4 ]
Roelants, Veronique [2 ]
Gheysens, Olivier [2 ]
Bailly, Sarah [3 ]
Krug, Bruno [1 ]
机构
[1] Univ Catholic Louvain, Dept Nucl Med, CHU UCL Namur, Godinne Site, Yvoir, Belgium
[2] Catholic Univ Louvain, Clin Univ St Luc, Dept Nucl Med, Leuven, Belgium
[3] Catholic Univ Louvain, Clin Univ St Luc, Dept Adult Hematol, Leuven, Belgium
[4] Catholic Univ Louvain, Nucl Med Dept, CHU UCL Namur, Dr G Therasse1 Ave,Godinne Site, B-5530 Yvoir, Belgium
关键词
diffuse large B-cell lymphoma; extramedullary hematopoiesis; FDG PET/CT; follow-up; PET SCANS; MARROW;
D O I
10.1097/RLU.0000000000004885
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 65-year-old man with a history of diffuse large B-cell bone lymphoma of the right radius underwent an interim FDG PET/CT after 2 cycles of chemotherapy. Besides a complete metabolic response on the primary site, images revealed a hypermetabolic nodule in the posterior mediastinum, not present on the initial images. The metabolic activity of the nodule was similar to that of the reactive bone marrow and disappeared, concomitantly to the normalization of the medullar signal on the posttreatment images. The similarity and synchronous metabolic activity evolution in the nodule and bone marrow indicate extramedullary hematopoiesis.
引用
收藏
页码:1066 / 1067
页数:2
相关论文
共 50 条
  • [41] Diffuse Large B-Cell Lymphoma - Rare Presentation
    Cordeiro, Rodrigo
    Chaves, Mariana
    JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY, 2022, 106 (01):
  • [42] Intracranial primary dural diffuse large B-cell lymphoma successfully treated with chemotherapy
    Carvalho Brito, Angelo Borsarelli
    Reis, Fabiano
    de Souza, Carmino Antonio
    Vassallo, Jose
    Passos Lima, Carmen Silvia
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (02): : 456 - 460
  • [43] Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA
    Morrison, Vicki A.
    Bell, Jill A.
    Hamilton, Laurie
    Ogbonnaya, Augustina
    Shih, Huai-Che
    Hennenfent, Kristin
    Eaddy, Michael
    Shou, Yaping
    Galaznik, Aaron
    FUTURE ONCOLOGY, 2018, 14 (25) : 2627 - 2642
  • [44] Diffuse large B-cell lymphoma variants: an update
    Sukswai, Narittee
    Lyapichev, Kirill
    Khoury, Joseph D.
    Medeiros, L. Jeffrey
    PATHOLOGY, 2020, 52 (01) : 53 - 67
  • [45] Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma
    Dobashi, Akito
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2016, 56 (02) : 71 - 78
  • [46] Guidelines for the management of diffuse large B-cell lymphoma
    Chaganti, Sridhar
    Illidge, Tim
    Barrington, Sally
    Mckay, Pam
    Linton, Kim
    Cwynarski, Kate
    McMillan, Andrew
    Davies, Andy
    Stern, Simon
    Peggs, Karl
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (01) : 43 - 56
  • [47] The use of tafasitamab in diffuse large B-cell lymphoma
    Duell, Johannes
    Topp, Max
    Salles, Gilles
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [48] Pembrolizumab for the treatment of diffuse large B-cell lymphoma
    Sheikh, Semira
    Kuruvilla, John
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (11) : 1119 - 1126
  • [49] Primary diffuse large B-cell lymphoma of the Larynx
    Higo, Ryuzaburo
    Kojima, Masataka
    Itoh, Shin
    Noguchi, Masaki
    Izumi, Hirosi
    Takeuchi, Kengo
    AURIS NASUS LARYNX, 2023, 50 (04) : 632 - 636
  • [50] Pidilizumab in the treatment of diffuse large B-cell lymphoma
    Bryan, Locke J.
    Gordon, Leo I.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (09) : 1361 - 1368